THE ROLE OF T LYMPHOCYTE FACTORS IN HEMOPOIESIS

T 淋巴细胞因子在造血中的作用

基本信息

  • 批准号:
    3192549
  • 负责人:
  • 金额:
    $ 18.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-04-01 至 1993-03-31
  • 项目状态:
    已结题

项目摘要

Inflammation is a complex host response that involves several biochemical pathways and all hemopoietic elements. T lymphocytes play an integral role in inflammatory responses by secreting soluble protein factors, lymphokines, that can regulate both the immunospecific and generalized aspects of the response. The first cells to arrive at a site of inflammation are neutrophilic granulocytes; macrophages usually appear several hours after granulocytes. Cloned T lymphocytes are a potent source of factors that affect hemopoiesis. The major hemopoietically active factor that is secreted by T lymphocytes is a granulocyte-macrophage colony-stimulating factor (GM-CSF). During an inflammatory response this GM-CSF may act distally on bone marrow cells to increase the number of responding granulocytes and macrophages. A major goal of this project is to purify to homogeneity the T lymphocyte GM-CSF. A highly enriched preparation of GM-CSF has been obtained with the use of high-pressure liquid chromatography. When serum free T lymphocyte-conditioned medium is used as a starting material, the GM-CSF will be purified to homogeneity. Another aim of this project is to determine the nature of the interaction between GM-CSF, IL3 (which is also produced by T lymphocytes), and erythropoietin. It has been shown already tha IL3 potentiates the effects of erythropoietin. However, T lymphocytes secrete about 10-100-fold more GM-CSF than IL3; the molecular basis for the net effect on bone marrow cells when all three factors are present in physiological or pathophysiological (i.e. during inflammation) concentrations is unknown but testable with pure factors. In addition, homogeneous GM-CSF will be subjected to mild proteolysis in an attempt to produce biologically active peptides to determine the minimal structural requirements that are necessary for biological activity. A longterm goal of this project will be to synthesize chemically bioactive peptides and structural analogs that can be used as either stimulatory or inhibitory effectors of hemopoiesis. These studies will further our understanding of the role that T lymphocytes play in regulating hemopoiesis.
炎症是一种复杂的宿主反应,涉及多种生化反应

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL B PRYSTOWSKY其他文献

MICHAEL B PRYSTOWSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL B PRYSTOWSKY', 18)}}的其他基金

Proteomic analysis of head & neck squamous cell cancer
头部蛋白质组学分析
  • 批准号:
    7534075
  • 财政年份:
    2004
  • 资助金额:
    $ 18.96万
  • 项目类别:
Proteomic analysis of head & neck squamous cell cancer
头部蛋白质组学分析
  • 批准号:
    6948627
  • 财政年份:
    2004
  • 资助金额:
    $ 18.96万
  • 项目类别:
Proteomic analysis of head & neck squamous cell cancer
头部蛋白质组学分析
  • 批准号:
    7535527
  • 财政年份:
    2004
  • 资助金额:
    $ 18.96万
  • 项目类别:
Proteomic analysis of head & neck squamous cell cancer
头部蛋白质组学分析
  • 批准号:
    7682892
  • 财政年份:
    2004
  • 资助金额:
    $ 18.96万
  • 项目类别:
Proteomic analysis of head & neck squamous cell cancer
头部蛋白质组学分析
  • 批准号:
    6836367
  • 财政年份:
    2004
  • 资助金额:
    $ 18.96万
  • 项目类别:
A1 REGULATED LEUKOCYTE APOPTOSIS DURING INFLAMMATION
炎症期间 A1 调节白细胞凋亡
  • 批准号:
    2670852
  • 财政年份:
    1998
  • 资助金额:
    $ 18.96万
  • 项目类别:
A1 REGULATED LEUKOCYTE APOPTOSIS DURING INFLAMMATION
炎症期间 A1 调节白细胞凋亡
  • 批准号:
    6170532
  • 财政年份:
    1998
  • 资助金额:
    $ 18.96万
  • 项目类别:
A1 REGULATED LEUKOCYTE APOPTOSIS DURING INFLAMMATION
炎症期间 A1 调节白细胞凋亡
  • 批准号:
    2887788
  • 财政年份:
    1998
  • 资助金额:
    $ 18.96万
  • 项目类别:
A1 REGULATED LEUKOCYTE APOPTOSIS DURING INFLAMMATION
炎症期间 A1 调节白细胞凋亡
  • 批准号:
    6373872
  • 财政年份:
    1998
  • 资助金额:
    $ 18.96万
  • 项目类别:
NOVEL T CELL ACTIVATION GENE IN DEVELOPING NEURONS
发育中神经元中的新型 T 细胞激活基因
  • 批准号:
    2890573
  • 财政年份:
    1996
  • 资助金额:
    $ 18.96万
  • 项目类别:

相似国自然基金

ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
  • 批准号:
    41606166
  • 批准年份:
    2016
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of advanced bioassay analysis system for internal dose assessment
开发用于内部剂量评估的先进生物测定分析系统
  • 批准号:
    23H03142
  • 财政年份:
    2023
  • 资助金额:
    $ 18.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
This service is for The BPN Biologics program requires bioassay development expertise in order to support active cooperative agreements for drug development and discovery.
该服务适用于 BPN Biologics 计划需要生物测定开发专业知识,以支持药物开发和发现的积极合作协议。
  • 批准号:
    10949343
  • 财政年份:
    2023
  • 资助金额:
    $ 18.96万
  • 项目类别:
Development of a three-dimensional microkidney model and its disease model for bioassay
用于生物测定的三维微肾脏模型及其疾病模型的开发
  • 批准号:
    23H01983
  • 财政年份:
    2023
  • 资助金额:
    $ 18.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
BIOASSAY SME CONSULTING SERVICES
生物测定中小企业咨询服务
  • 批准号:
    10837635
  • 财政年份:
    2022
  • 资助金额:
    $ 18.96万
  • 项目类别:
Development of a qualified pharmacokinetic bioassay to support preclinical and clinical studies of MM-008, a non-hormonal contraceptive antibody
开发合格的药代动力学生物测定法以支持非激素避孕抗体 MM-008 的临床前和临床研究
  • 批准号:
    10459074
  • 财政年份:
    2022
  • 资助金额:
    $ 18.96万
  • 项目类别:
BIOASSAY SME CONSULTING SERVICES
生物测定中小企业咨询服务
  • 批准号:
    10721007
  • 财政年份:
    2022
  • 资助金额:
    $ 18.96万
  • 项目类别:
Development of rapid and sensitive bioassay methods to contribute to actinide internal exposure medical response
开发快速、灵敏的生物测定方法,有助于锕系元素内照射医疗反应
  • 批准号:
    22K12384
  • 财政年份:
    2022
  • 资助金额:
    $ 18.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
BIOASSAY SME CONSULTING SERVICES
生物测定中小企业咨询服务
  • 批准号:
    10721008
  • 财政年份:
    2022
  • 资助金额:
    $ 18.96万
  • 项目类别:
Development of simple bioassay for detection of environmental trace contaminants and demonstration in Asian countries
开发用于检测环境痕量污染物的简单生物测定法并在亚洲国家进行示范
  • 批准号:
    21H01577
  • 财政年份:
    2021
  • 资助金额:
    $ 18.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
L2M Market Assessment Grant: a bioassay to predict birth timing.
L2M 市场评估补助金:预测出生时间的生物测定。
  • 批准号:
    571251-2022
  • 财政年份:
    2021
  • 资助金额:
    $ 18.96万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了